• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

DANAHER CORPORATION

Notes

No. Proposition For Against Abstain
1

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair

2

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan

3

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler

4

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna

5

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List

6

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales

7

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales

8

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders

9

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon

10

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D

11

Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD

12

To ratify the selection of Ernst & Young LLP as Danahers independent registered public accounting firm for the year ending December 31, 2026.

13

To approve on an advisory basis the Companys named executive officer compensation.

14

To approve the Companys Amended and Restated Omnibus Incentive Plan.